Sarah Mougalian, MD

Assistant Professor of Medicine (Medical Oncology); Assistant Professor in Medicine (Medical Oncology)

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Geriatric
Referrals: From patients or physicians

Patient Care Organizations

Cancer Center, Yale: Breast Cancer Program

Subset Medical Oncology Faculty

Yale Medical Group

Board Certifications

  • Internal Medicine AB of Internal Medicine (2009)

  • Medical Oncology AB of Internal Medicine (2013)

  • Hematology (Internal Medicine) AB of Internal Medicine (2013)

Clinical Trials

Conditions Study Title
Breast - Female Randomized study comparing MPDL3280A with Nab-Paclitaxel compared to placebo with Nab-Paclitaxel
Breast - Female GDC0810 in Postmenopausal Women w/ Locally Advanced/Metastatic Estrogen Recep Positive breast cancer
Breast - Female, Breast - Male Olaparib as Adjuvant Treatment in Patients With BRCA Mutated High Risk HER2 Negative breast cancer
Breast - Female BETA Trial
Breast - Female, Breast - Male MM-302 Plus Trastuzumab vs. Chemotherapy Plus Trastuzumab in HER2-positive MBC
Breast - Female Neoadj ph 2 AI plus everolimus in postmenopausal women w/ ER pos/HER2 neg, low risk score
Breast - Female, Breast - Male Phase 2, Randomized, open label study of Lucitanib in FGF abberrant metastatic breast cancer
Breast - Female An Observational Cohort Study of Tx Patterns & Outcomes in Pts w/HER2+ Metastatic Breast Cancer
Breast - Female, Breast - Male Phase II with Orteronel as Monotherapy for Metastatic Breast Cancer that expresses Androgen Receptor
Breast - Female Phase I Study of SGN-LIV1A via IV Infusion in Patients with LIV-1-positive Metastatic Breast Cancer
Breast - Female, Breast - Male S1207 Phase 3 Rand, Adj Endocrine Tx plus Everolimus in High risk ER/PR + HER2neg BC
Anus, Bladder, Breast - Female, Breast - Male, Cervix Uteri, Colon, Esophagus, Kidney, Larynx, Liver, Lung, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs Phase I with GDC-0032 for Tx of Local Advanced or Metastatic Solid Tumors or HER2+ Breast Cancer
Breast - Female Neo-Adj, Phase 2, Pertuzumab and Trastuzumab with weekly Paclitaxel and FEC, HER2-pos Breast Cancer
Breast - Female, Breast - Male Breast Cancer Molecular Analysis Prior to Investigational Therapy (MAP-IT)

Edit this profile

Contact Info

Sarah Mougalian, MD
Patient Care Location
Yale Cancer CenterYale-New Haven Hospital
20 York Street, Ste North Pavilion 1

New Haven, CT 06510
View on map...
Mailing Address
25 York Street
PO Box 208028

New Haven, CT 06510

Curriculum Vitae